In part, the guidance is updated to reflect differences for equine parvovirus-hepatitis and equine hepacivirus ...

Chronic hepatitis B, caused by persistent infection with HBV, puts >250 million people at risk to develop terminal liver disease. HBV persistence is mediated by an intranuclear, episomal form of the ...

The viral illness kills more people in the city than HIV, but antiviral medications may be helping cut its transmission.

GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

Infection with hepatitis D viruses causes severe inflammation of the liver. An MHH team has now identified a marker on natural killer cells that is influenced by the anti-inflammatory effectiveness of ...

That is about to change, with $6 million awarded to National Cancer Centre Singapore (NCCS) senior consultant surgeon Pierce ...

Investors' focus will likely be on GILD's HIV franchise performance and oncology sales when the company reports ...

Those included, by 2030: 90% diagnosis of viral hepatitis C infection worldwide; 80% treatment of eligible candidates with chronic hepatitis C; a 90% reduction in new cases of chronic hepatitis C ...

against HBV as a novel treatment approach to chronic hepatitis B (CHB) in mouse models. Methods Therapeutic effects of mAbs against various epitopes on viral surface protein were evaluated in mice ...

New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.

The administration officer will be a key member of the Inflammatory Bowel Disease (IBD) team, working alongside the IBD clinical nurse consultants (IBDCNC) and Nurse Practitioner (NP) providing ...

China: A recent study published in the Annals of Hepatology has emphasized the influence of age on hepatocellular carcinoma ...